Blood Work You Need in 2025: GlycA and Inflammation

A client’s lab printout is on the screen, and the moment lands because it is familiar. The person is not asking for a “biohacker panel.” They are asking a simple question: Is this inflammation number a big deal, or not?

That is the video’s unique perspective in a sentence. Stop treating inflammation like a single on or off switch, and start treating it like a pattern you can triangulate.

The discussion centers on a composite marker called GlycA (often written GlycA, sometimes said as “glyc”), and the practical idea is straightforward: pair it with hs-CRP (high-sensitivity C-reactive protein) to better understand chronic inflammation and related risk.

A practical 2025 lab story: when “normal CRP” is not the whole picture

Inflammation is common, and it gets more common with age.

The video frames this as inflammaging (the gradual rise in baseline inflammatory tone as we get older). At the same time, the talk highlights another aging pattern: blood sugar handling often worsens over time, meaning many people become more insulin resistant unless they actively counter it with lifestyle.

That combination matters because a lot of “metabolic health” risk is not one lab value. It is the way multiple signals move together over months and years.

A misconception the video pushes back on is the idea that one “good” marker ends the conversation. If CRP is very low, the speaker suggests you may not need to go hunting for extra inflammation tests. But if CRP is consistently elevated, the message is that you should not stop there.

Did you know? Low-grade chronic inflammation is linked in research to cardiometabolic risk, and inflammation markers can add context to traditional risk tools. One reason hs-CRP is commonly used is that it has been studied for cardiovascular risk prediction in large populations, including in guidance documents like the CDC and AHA statement on hs-CRPTrusted Source.

GlycA, the “newish” inflammation marker most people are not getting

GlycA is presented as a composite immunologic marker that has been in the literature since about 2015, but is still underused in everyday practice.

Unlike a single cytokine test, GlycA aims to summarize information from multiple acute-phase proteins (proteins that shift during inflammation) and their glycosylation patterns. In plain language, it is not just “how much inflammation protein is present,” it is also “what does the inflammatory protein signature look like.”

What GlycA is measuring, in plain language

The talk emphasizes that GlycA is assessed via NMR (nuclear magnetic resonance), the same broad platform many people associate with advanced lipoprotein particle testing.

Here is the key mechanism the video keeps returning to: GlycA reflects glycosylation and acetylation patterns on inflammatory proteins (including immunoglobulin-related signals) that tend to increase in inflammatory contexts. You can think of it as a stable fingerprint of inflammatory activity, rather than a single snapshot.

This “fingerprint” framing is consistent with published descriptions of GlycA as an NMR-derived marker reflecting circulating glycoprotein acetylation signals, and it has been studied across cardiometabolic and inflammatory conditions. For background on CRP and inflammation biology, a helpful overview is the MedlinePlus CRP test pageTrusted Source.

Why it is not just another trendy lab

The video’s argument is not “order every new test.” It is “use the right test when the situation calls for it.”

If hs-CRP is low (the speaker gives an example around 0.8), the practical takeaway is that you probably do not need to add more inflammation testing just for the sake of it.

But when hs-CRP is elevated or persistently borderline, the video treats GlycA as a way to reduce uncertainty.

Why the video pairs CRP plus GlycA (instead of chasing one number)

hs-CRP is useful, but it is also nonspecific.

A cold, a recent viral exposure, an injury, a dental issue, poor sleep, visceral fat, or a flare of an inflammatory condition can all move CRP. This is why people often feel confused when they get a CRP result that is higher than expected.

The approach here is to pair a “fast moving smoke alarm” (CRP) with a “more stable composite signal” (GlycA).

What the research shows: In chronic inflammatory diseases, traditional cardiovascular risk tools and standard inflammation markers may miss high-risk individuals, and adding GlycA may improve risk characterization in some settings. One review discussing this concept is “GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular risk in chronic inflammatory diseases” (summary available through journal platforms such as PubMedTrusted Source, search by title).

This pairing is also used in the video to address a specific population that comes up often in metabolic health communities: people with elevated LDL cholesterol who are otherwise lean and metabolically healthy (sometimes called “lean mass hyper responders”). The point is not that GlycA replaces lipids. It is that inflammation context can change how you interpret risk conversations.

A practical misconception the video challenges is that “lipids alone decide everything.” The discussion suggests that when inflammation is high, cardiovascular risk may be higher than the lipid panel alone implies. When inflammation is low, risk interpretation may look different, and the conversation may shift toward overall metabolic context.

Interpreting real-world results: the CRP 3 and GlycA 400 example

The most concrete moment in the video is a real lab example.

CRP is around 3, described as near the upper tolerable limit. GlycA is close to 400.

The speaker’s practical threshold message is memorable: if GlycA is close to or above 400 and CRP is above 3, that combination is framed as a problem worth taking seriously and discussing with a clinician.

This is not presented as a diagnosis. It is presented as a risk signal, and as a reason to look for drivers.

Why those two numbers together matter in this framing

One elevated marker can be noise.

Two elevated inflammation markers that reflect different aspects of biology are more likely to be signal.

In the video’s reasoning, CRP can be elevated for many short-term reasons, but GlycA may better reflect more chronic, smoldering inflammation. So when both are up, it increases confidence that something persistent is going on.

That “triangulation” mindset is one of the most useful parts of the talk. It discourages panic over one lab and encourages pattern recognition across labs.

Important: If you have a persistently elevated hs-CRP, especially above common clinical cut points, it is worth reviewing potential causes with a healthcare professional, including infection, inflammatory disease, sleep apnea, smoking, dental disease, medication effects, and cardiometabolic factors. hs-CRP is nonspecific, and interpretation depends on context. For general guidance on hs-CRP use in risk assessment, see the AHA guidance discussionTrusted Source.

Ferritin, inflammation, and the “metabolic hyperferritinemia” idea

Ferritin shows up in the video as part of the same client example.

The ferritin number is striking, around 726 ng/mL, which is far above what many people see on routine labs. The discussion notes that many women may see ferritin more like 50 to 75 ng/mL, though ranges vary by lab and individual.

The video frames a key misconception: high ferritin is not automatically the same thing as classic iron overload disorders. Ferritin can rise as an acute-phase reactant, meaning it can increase with inflammation, liver stress, metabolic dysfunction, and other conditions.

This is where the speaker introduces the idea of metabolic hyperferritinemia. The claim is that, in some people, ferritin elevation may reflect metabolic and inflammatory drivers rather than a primary genetic iron overload condition.

The practical point is not to self-interpret ferritin in isolation. It is to look for corroborating markers and to work with a clinician on appropriate evaluation.

A helpful general reference on ferritin testing and what it can indicate is the MedlinePlus ferritin test pageTrusted Source.

What to do when other markers are off: fibrinogen, WBC, and fatigue labs

The video is a live Q and A, and several questions reveal how people actually experience lab testing in the real world.

Some questions are about specific symptoms, others about confusing lab shifts, and a few are about supplements that seem to cause odd reactions.

Fibrinogen: a lifestyle lever the video keeps coming back to

One viewer asks how to bring down a high fibrinogen level.

The response is practical: first ask why it is elevated, then focus on lifestyle levers that plausibly reduce clotting risk and inflammatory tone. The video emphasizes:

This is consistent with broader evidence that reducing sedentary time and increasing physical activity improves cardiometabolic risk factors. For general physical activity guidance, see the CDC recommendations for adultsTrusted Source.

Pro Tip: If you sit most of the day, set a timer for every 30 to 60 minutes and do 2 to 5 minutes of easy movement. A short walk after meals is often easier to sustain than a single long workout.

Low white blood cell count on keto or carnivore patterns

Another viewer asks about gradually decreasing white blood cell counts on a long-term keto or carnivore diet.

The response is cautious and observational: this can happen, and the suggested next step is to follow it over time and look at the full blood count context, not just WBC alone. The video mentions checking:

The speaker also mentions a specialty option, a lymphocyte proliferation index (LPI) through SpectraCell, framed as a way to explore immune function and micronutrient-related proliferation issues. This is not presented as a routine test for everyone, more as a tool in unusual scenarios.

Fatigue, vitamins, hormones, and Lyme testing

A viewer describes “overbearing tiredness,” with labs showing low vitamin B levels, normal testosterone, and high estrogen, with Lyme testing planned.

The video does not treat this as a one-lab answer. Instead, it reflects the broader theme: fatigue can have many contributors, and labs are a starting point for a clinician-guided workup.

For readers, the practical takeaway is to avoid anchoring on a single lab value as the explanation for fatigue. If fatigue is persistent, it is reasonable to discuss a structured evaluation with a healthcare professional, potentially including sleep quality, iron studies, thyroid markers, B12 and folate status, medication review, mood and stress, and infection risk when appropriate.

Kidney health labs the video wants you to remember

A particularly sobering moment is a comment about two middle-aged men with type 2 diabetes progressing to kidney failure and dialysis.

The video responds with a specific lab suggestion that is easy to miss in routine care: the urine albumin-to-creatinine ratio.

This matters because early kidney damage can show up as abnormal albumin leakage into urine before major changes appear in serum creatinine. Many guidelines emphasize urine albumin testing for diabetes and hypertension monitoring.

For background on chronic kidney disease screening and albuminuria, see the National Kidney Foundation overview of urine albumin-to-creatinine ratioTrusted Source.

A second practical nuance appears later in the Q and A: creatine supplementation can increase serum creatinine in some people, and this can confuse casual interpretation of kidney labs. That does not automatically mean kidney damage, but it is a reason to interpret creatinine-based estimates with context and to involve a clinician.

How to actually get GlycA and build a smarter annual lab plan

The video is not subtle about the goal: democratize access to useful labs, and make annual lab testing more strategic.

A viewer asks where to get GlycA. The response points to ordering through common lab systems, and mentions a panel context (an MVX panel through Labcorp is referenced) where GlycA can be added. The speaker also notes a rough cost, around $50 in that bundled context, though prices vary by region, ordering pathway, and insurance.

This is paired with a practical recommendation: bring a lab “cheat sheet” to your clinician and ask for the specific add-ons that match your situation.

A simple decision rule from the video

The talk offers a very usable rule of thumb:

That is the unique perspective. Not “everyone needs every test,” but “use a second marker when the first marker raises questions.”

How to talk to your clinician about it

If you want to adopt this approach, consider bringing these specific discussion points to your appointment:

»MORE: If you keep a personal health file, add a simple “lab timeline” page. Record the date, the reason you tested (annual checkup, illness, training block), and 5 to 10 key markers. Patterns become obvious faster than you expect.

A note on “new tools” vs “more tools”

The video’s focus is inflammation, but it also includes side discussions about supplements (notably creatine sourcing and magnesium forms) and how they can affect labs or symptoms.

The most important meta-point is this: more testing is not always better. Better testing is better.

If you add GlycA, do it because you have a question that GlycA can help answer, such as whether elevated CRP is likely transient or part of a chronic inflammatory pattern.

Key Takeaways

Q: If my hs-CRP is normal, should I still order GlycA?

A: The video’s practical stance is “usually no.” If hs-CRP is low (an example given is about 0.8), GlycA may not add much for most people. If hs-CRP is repeatedly elevated or you have higher cardiometabolic risk, GlycA may help clarify whether inflammation looks more chronic.

Video presenter, metabolic health educator

Q: What if my white blood cell count is low on keto or carnivore?

A: The video suggests monitoring trends over time and looking at the full CBC context, including platelets, red blood cells, and the neutrophil-to-lymphocyte ratio. If the pattern is worsening, or you have symptoms or recurrent infections, it is reasonable to review it with a clinician.

Video presenter, metabolic health educator